Search research articles
Contact Us
Filters
Showing results (61-70 of 115) with videos related to
Page
of 12
Sort By:
Antimicrobial Agents and Chemotherapy
|
August 26, 2004
Impact of alpha interferon and ribavirin on the function of maturing dendritic cells
Eleanor Barnes, Mariolina Salio, Vincenzo Cerundolo, et al.
Journal of Hepatology
|
September 17, 2015
Reply to "Debilitating fatigue as a treatment indication in chronic hepatitis C"
Jean-Michel Pawlotsky, Alessio Aghemo, David Back, et al.
Hepatology (Baltimore, Md.)
|
November 9, 2019
Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy
Ivana Carey, Jeffrey Gersch, Bo Wang, et al.
Journal of Viral Hepatitis
|
December 5, 2019
Hepatitis B in sub-Saharan Africa-How many patients need therapy?
Mark W Sonderup, Geoffrey Dusheiko, Hailemichael Desalegn, et al.
Journal of Hepatology
|
October 6, 2018
Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B
Mindie H Nguyen, A Burak Ozbay, Iris Liou, et al.
Pharmacoeconomics - Open
|
January 3, 2024
Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies
Ankita Kaushik, Geoffrey Dusheiko, Chong Kim, et al.
Advances in Therapy
|
July 14, 2022
Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures
Michelle E Orme, Roy Bentley, Stephen Marcella, et al.
Springerplus
|
July 21, 2015
IL28B genotype predicts response to chronic hepatitis C triple therapy with telaprevir or boceprevir in treatment naïve and treatment-experienced patients other than prior partial- and null-responders
Giorgio Calisti, Amanda Tavares, Malcolm J Macartney, et al.
Hepatology (Baltimore, Md.)
|
September 4, 2018
Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B
Mindie H Nguyen, Joseph K Lim, A Burak Ozbay, et al.
Journal of the American Geriatrics Society
|
May 26, 2018
Efficacy and Tolerability of Direct-Acting Antivirals for Hepatitis C in Older Adults
Chiara Mazzarelli, Aisling Considine, Kate Childs, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 115) with videos related to
Sort By:
Page
of 12
Antimicrobial Agents and Chemotherapy
|
August 26, 2004
Impact of alpha interferon and ribavirin on the function of maturing dendritic cells
Eleanor Barnes, Mariolina Salio, Vincenzo Cerundolo, et al.
Journal of Hepatology
|
September 17, 2015
Reply to "Debilitating fatigue as a treatment indication in chronic hepatitis C"
Jean-Michel Pawlotsky, Alessio Aghemo, David Back, et al.
Hepatology (Baltimore, Md.)
|
November 9, 2019
Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy
Ivana Carey, Jeffrey Gersch, Bo Wang, et al.
Journal of Viral Hepatitis
|
December 5, 2019
Hepatitis B in sub-Saharan Africa-How many patients need therapy?
Mark W Sonderup, Geoffrey Dusheiko, Hailemichael Desalegn, et al.
Journal of Hepatology
|
October 6, 2018
Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B
Mindie H Nguyen, A Burak Ozbay, Iris Liou, et al.
Pharmacoeconomics - Open
|
January 3, 2024
Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies
Ankita Kaushik, Geoffrey Dusheiko, Chong Kim, et al.
Advances in Therapy
|
July 14, 2022
Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures
Michelle E Orme, Roy Bentley, Stephen Marcella, et al.
Springerplus
|
July 21, 2015
IL28B genotype predicts response to chronic hepatitis C triple therapy with telaprevir or boceprevir in treatment naïve and treatment-experienced patients other than prior partial- and null-responders
Giorgio Calisti, Amanda Tavares, Malcolm J Macartney, et al.
Hepatology (Baltimore, Md.)
|
September 4, 2018
Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B
Mindie H Nguyen, Joseph K Lim, A Burak Ozbay, et al.
Journal of the American Geriatrics Society
|
May 26, 2018
Efficacy and Tolerability of Direct-Acting Antivirals for Hepatitis C in Older Adults
Chiara Mazzarelli, Aisling Considine, Kate Childs, et al.
Page
of 12